Interestingly, in all the datasets analysed, a low SORT1 expression was associated with poor overall and disease-free survival in adenocarcinomas, while in SCC, either non-significant or borderline trends with favourable outcome were derived between SORT1 expression and survival. This evidence concerns the gene SORT1 and adenocarcinoma.